$330.23
+1.27(0.39%)
Mkt Cap $13.0B
$225.54
$359.40
52-Week Range
At A Glance
1
Penumbra, Inc.
2
Revenue is primarily driven by Thrombectomy (66.7%) and Embolization (33.3%).
3
Most recently: . Results of Operations and Financial Condition. On February 25, 2026 , Penumbra, Inc. issued a press release announcing financial results for the fourth fiscal (2026-02-25).
$13.0B
Market Cap
$1.4B
Revenue
$178M
Net Income
Employees4,500
Fundamentals
How The Business Makes Money
Revenue by Segment
Thrombectomy66.7%($2.4B)
Embolization33.3%($1.2B)
Revenue by Geography
US75.2%($2.8B)
Non Us24.8%($906M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001321732
ISINUS70975L1070
CUSIP70975L107
Phone510 748 3200
AddressOne Penumbra Place, Alameda, CA, 94502, US
SEC EDGAR